2 completed, 1 withdrawn. 1 Early Phase 1, 1 Not applicable, 1 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Completed 1 |
| Not applicable | 1 | Completed 1 |
| Phase 2 | 1 | Withdrawn 1 |
| Phase 3 | 1 | Withdrawn 1 |
Follow Normosol-R: new trials by email Literature Review of Normosol-R trials Research Report on Normosol-R
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hypertonic Saline in Posterior Spinal Fusion Normosol-R, buffered 2% hypertonic saline - Scoliosis Idiopathic, Scoliosis;Congenital | Phase 2 / Phase 3 | Withdrawn | Joseph D. Tobias | 2025-12-01 | 2025-11-10 | |
| Balanced Solutions and Plasma Electrolytes Lactated Ringer's, Normosol - Critical Illness, Acidosis, Metabolic | Not applicable | Completed | Vanderbilt University Medical Center | 2093 | 2018-06-01 | 2019-10-11 |
| A Pilot Study for Toxicity Evaluation of HIV Rectal Microbicides Normosol-R, Nonoxynol-9, Gastrointestinal instrumentation - HIV Infections | Early Phase 1 | Completed | Johns Hopkins University | 12 | 2007-04-01 | 2015-04-01 |
Acidosis (1) · Critical Illness (1) · HIV Infections (1)
Johns Hopkins University (1) · Joseph D. Tobias (1) · Vanderbilt University Medical Center (1)
United States (3)
Edward Fuchs, PA-C, MBA (1) · Matthew W Semler, MD, MSc (1)